MRP ₹6000
(Inclusive of all Taxes)
₹900.0 Cashback (15%)
Provide Delivery Location
About Mydekla 60Mg 28 Tablets
Mydekla 60Mg 28 Tablets is an antiviral medicine used along with sofosbuvir, with or without ribavirin, to treat chronic hepatitis C viral genotype 1 or 3 infection. It is a serious infection caused by the hepatitis C virus. It is a contagious infection that spreads from person to person and affects the liver. Mydekla 60Mg 28 Tablets is only used in treating the infection. It does not cure or prevent further liver complications.
Mydekla 60Mg 28 Tablets contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.
Mydekla 60Mg 28 Tablets may cause certain side effects such as headache, fatigue, weakness, confusion, chest pain, nausea, diarrhoea, shortness of breath, dizziness and lightheadedness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. Use it as suggested by your doctor. Your doctor will decide the duration of the medicine based on your health condition.
Mydekla 60Mg 28 Tablets should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Mydekla 60Mg 28 Tablets is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, kidney problems, or HIV infection, as it may cause serious side effects. Mydekla 60Mg 28 Tablets may cause hepatitis B infection reactivation and bradycardia (slow heart rate) in some patients. Hence, patients should be monitored carefully for any changes.
Uses of Mydekla 60Mg 28 Tablets
Mydekla 60Mg 28 Tablets is used in the treatment of Hepatitis C virus infection. The detailed use of Mydekla 60Mg 28 Tablets is as follows:

Have a query?
Directions for Use
Key Benefits
Mydekla 60Mg 28 Tablets contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and, therefore, reduces the amount of hepatitis C virus in the body.
How Mydekla 60Mg 28 Tablets Works
Storage
What if I have taken an overdose of Mydekla 60Mg 28 Tablets
Drug Warnings
Mydekla 60Mg 28 Tablets should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Mydekla 60Mg 28 Tablets is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, other kidney problems, or HIV infection, as it may cause serious side effects. Mydekla 60Mg 28 Tablets may cause hepatitis B infection reactivation and bradycardia in some patients. Hence, patients should be monitored carefully for any changes.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXAprazer Healthcare Pvt Ltd
₹3500
(₹102.5 per unit)
RXMylan Pharmaceuticals Pvt Ltd
₹5000
(₹146.43 per unit)
RXZydus Healthcare Ltd
₹5000
(₹146.43 per unit)
Alcohol
Safe if prescribed
It is not known if Mydekla 60Mg 28 Tablets interacts with alcohol. Please consult your doctor.
Pregnancy
Consult your doctor
If you are pregnant or planning pregnancy, inform your doctor before taking Mydekla 60Mg 28 Tablets. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
If you are a nursing mother, inform your doctor before taking Mydekla 60Mg 28 Tablets. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Safe if prescribed
It is not known if Mydekla 60Mg 28 Tablets affects your ability to drive. Do not drive or operate heavy machinery if you are not alert.
Liver
Consult your doctor
If you have a history of liver disease, inform your doctor before taking Mydekla 60Mg 28 Tablets. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Consult your doctor
If you have a history of kidney disease, inform your doctor before taking Mydekla 60Mg 28 Tablets. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Safe if prescribed
Mydekla 60Mg 28 Tablets is not recommended for use in children below 18 years of age, as efficacy and safety have not been established.
Heart
Mydekla 60Mg 28 Tablets should be used with caution and under medical supervision in patients with heart problems. Therefore, please consult your doctor before using Mydekla 60Mg 28 Tablets.
Geriatrics
Consult your doctor
Mydekla 60Mg 28 Tablets is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Mydekla 60Mg 28 Tablets is used to treat Hepatitis C virus infection.
Mydekla 60Mg 28 Tablets contains Daclatasvir, which works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.
Avoid receiving Mydekla 60Mg 28 Tablets if you are allergic to it or other medicines of the same class. Also, this medicine should not be used along with CYP3A inducer drugs such as rifampicin, carbamazepine, phenytoin, etc., as it can cause serious adverse effects. Concomitant use of Mydekla 60Mg 28 Tablets along with amiodarone should be avoided due to the risk of severe bradycardia (slow heart rate).
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information